Objective: Lymphoma is the cancer of lymphatic system. Treatment strategy of lymphoma depends upon the staging of disease. Accurate staging can guide the required regimen and can minimize the therapeutic toxic effect and reduces the morbidity and mortality associated with over treatment. The purpose of this study was to observe the upstaging or down staging of lymphoma patients at baseline by performing PET-CT imaging over clinical staging who were referred to National Institute of Nuclear Medicine & Allied Sciences (NINMAS) for baseline staging. Patients and Methods: This cross sectional observational type of study was carried out in NINMAS from July 2017 to June 2018. A total of 26 newly diagnosed lymphoma patients referred to NINMAS for PET-CT scan for baseline staging were included in this study. Results: Out of the 26 patients (14male and 12 female; mean age: 43.42 ± 17.98 years), 14(53.8%) patients were diagnosed with Hodgkin Lymphoma and 12(46.2%) with Non Hodgkin Lymphoma. In this study, 14(53%) patients were upstaged in PET-CT scan based staging in comparison to clinical staging. Key lesion was assessed by SUVmax in PET-CT scan of different stages of lymphoma. Highest key lesion was found in stage IV.
INTRODUCTION
Lymphoma is a heterogeneous group of malignant neoplasm of the reticuloendothelial system, which may be subdivided broadly into Hodgkin lymphoma (HL) and Non Hodgkin lymphoma (NHL). In a study, prevalence of NHL is 16.9% and HL is 3.9% among all hematological malignancies in Bangladesh (1) .NHL is more common which represents 85% of all lymphoma. HL is subdivided into classical and non-classical type. Non-classical type represents nodular lymphocyte predominant variety. According to prognosis NHL is subdivided into aggressive and indolent lymphoma. Indolent lymphoma has better prognosis with median survival of about 10 years. Follicular lymphoma is the most common indolent lymphoma and diffuse large B-cell lymphoma (DLBCL) is the most aggressive type (2) .
Clinical presentation of lymphoma depends on anatomical distribution of disease. Patients usually present with enlarged non tender lymph nodes in HL and two-third of NHL. Remaining one-third of NHL present with symptoms associated with involvement of extra nodal sites like skin, stomach or brain. Treatment strategy of lymphoma depends upon the staging of disease which defines disease location, extension, suggests prognostic information and provides a baseline against which treatment response or disease progression can be compared (3) . Accurate staging can minimize the therapeutic toxic effect and reduces the morbidity and mortality associated with therapy. PET-CT is a noninvasive, three-dimensional, metabolic imaging technique consists of PET by 18F-FDG that can detect glucose metabolism within the cell and low dose CTwhich is used for anatomical location. PET-CT plays a critical role as a baseline measurement before therapy which increases the accuracy of subsequent response assessment. Accurate staging used for pretreatment risk stratification and selection of therapy those ensure fewer patients are undertreated or over treated (4) . More than 90% of patients with newly diagnosed HL are curable with radiation therapy alone or combination of chemotherapy and radiotherapy (5) . Correct staging is important for the selection of appropriate treatment regimen for lymphoma patients.
involved with malignant lymphoma before the structural changes become visible (2) . In 1999, the National Cancer Institute Working group first published universally accepted guidelines for performing and interpreting PET imaging using 18F FDG, immunohistochemistry and flow cytometry to see the treatment response criteria for both HL and NHL. These criteria were revised in 2007 by the International Working Group (IWG) (4) .International Conference on Malignant Lymphoma (ICML) working group recommended PET-CT as the gold standard for routine staging of FDG avid nodal lymphoma (3).
In Bangladesh, staging of lymphoma is mainly based on conventional staging method. PET-CT is available as regular weekly service since January 2016 at NINMAS. No study has been done yet in Bangladesh to see the extent of variation in staging of both pediatric and adult lymphoma between conventional and PET-CT based staging. This study was designed to analyze the clinical staging and PET-CT based staging in diagnosed lymphoma patient at baseline so that to establish PET-CT based staging in lymphoma patients at baseline in routine use in Bangladesh.
PATIENTS AND METHODS
This cross sectional observational type of study was carried out at NINMAS, BSMMU campus, Dhaka during the period of July 2017 to June 2018. Newly diagnosed lymphoma patients referred to the institute (NINMAS) for baseline staging were included in this study. A total of 26 patients were enrolled in this study. All the patients were informed of the potential risks and benefit of the procedure and informed consent was taken from each individual case before inclusion in the study. Details of the clinical history, histopathological report and immuno-histochemistry reports were recorded in a structured data sheet. Lymphoma diagnosis was confirmed by histopathology and Immuno-histochemistry reports.
Clinical staging (Ann Arbor staging) was done by clinical history and physical examination. 18F-FDG was administered intravenously after 6 hours fasting. To allow the distribution and uptake of radiotracer, the patient was kept in resting quietly for 60 minutes in a shielded room. Imaging was performed with GE-DiscoveryTM PET-CT-series 710 with LYSO crystal scanner on an integrated 128-slice CT. Scan was performed from vertex to mid-thigh, 2 minutes per bed usually with 9 bed positions; this varies according to height of the patient. Serum blood glucose level was <8.0 m mol/L at the time of injection. SUV is calculated as SUV bw gm /ml. Images were reviewed in the transaxial, coronal and sagittal planes. High resolution CT scan without contrast was performed for attenuation correction before PET acquisition. Interpretation done by experienced nuclear medicine physician and radiologist. Staging of lymphoma patients were done according to ( Figure: patients were in stage IV by PET-CT staging ( Table 3) . Highest SUVmax of key lesion was found in stage 4. 
DISCUSSION
Lymphoma is a heterogeneous group of diseases which represents the fifth most common malignancy in the United States (6) . HL typically originates in lymphoid tissues which tends to develop in an orderly fashion and can spread to other organs. On the other hand, NHL is a heterogeneous group of lymphoproliferative malignances with different patterns of behavior and varying response to treatment (7) . More than 90% of patients with newly diagnosed HL are curable with radiation therapy alone or combination of chemotherapy and radiotherapy (5) .
Correct staging is important for the selection of appropriate treatment regimen for lymphoma patients. Overall, the average age at the time of diagnosis is 39.
However, it has a bimodal variation with one peak in early years of life and other after middle age (8) .
The incidence of lymphoma is predominant in male than female. The incidence of lymphoma in males was higher in earlier age, but in older ages the incidence of lymphoma in female increases and approaches nearly that of males (8) found 81.6% NHL and 18.3% HL in one study (8) .
Pelosi E.et al (2008) also found the similar findings (12) . Majority of the study showed higher proportion of NHL as compared to HL. Immuno-suppression is the well established risk factor for the development of non-Hodgkin lymphoma. Patients with HIV have an increased risk for high-grade non-Hodgkin lymphoma (7) . On the other hand, HL is one of the most frequent lymphomas in the Western world. The annual incidence is about 3 cases per 100,000 persons (13) . found Cervical lymph nodes was the most common site (20.7%) followed by axillary nodes (14.35%) and the inguinal nodes (7.9%), which were similar to the current study (14) .If the largest dimension of a node or nodal mass is 10 cm or greater it is defined as bulky. In this study, no bulky disease was found.
In this study, it was observed that out of 14 cases of HL, are consistent with the current study (14) . PET-CT can be used to observe the responses and to guide further therapy in the view of improving treatment outcome. A five-point scale (5-PS) is used for visual assessment to see the degree of response at mid and end of the treatment. The preferable reference scale should be the mediastinum and the liver. This scale was recommended as the standard reporting tool at the First International Workshop on PET in Lymphoma in Deauville, France, in 2009, and these so-called Deauville criteria (16) .Deauville criteria is used to see the treatment response based on scoring. It can predict treatment response and categorize disease after chemotherapy and radiotherapy.
In this study, PET-CT scan was done on 26 patients of diagnosed lymphoma to find out any change with clinical staging. Result showed that the PET-CT led to change in the clinical staging in 53% of patients.
No change in the clinical stage was found in 47% of patients. Three patients, who were prior grouped as stage I on clinical staging, were upstaged to stage II, 3 patients from stage I toIII and another from stage I-IV. One patient was upstaged from stage II to III and 5 patients from stage II to IV. One patient was upstaged from stage III to IV. There was no patient at stage IV on clinical staging but 7 patients were found at stage IV based on PET-CT scan staging (Table 6 ). Barrington upstaged and only 1% down staged for NHL (15) .
Regarding the changes of lymphoma staging at baseline using PET-CT scan in comparison to clinical staging, majority of the study showed that upstaging was more than that of the down staging which are comparable with the current study. Few of the study showed more down staging is more than upstaging. Upstaging was due to SUVmax. In this current study, it was observed that, SUVmax of key lesions were found in stage I ranged from 7.5-9.0, in stage II ranged from 9.4-11, in stage III ranged from 12.6-19 and in stage IV ranged from 17.9-22.7 ( Table 5 ). Highest SUVmax of key lesion was found in stage IV. One study was done in NINMAS before this study about PET-CT on staging of baseline lymphoma in pediatric age group (19) . SUVmax of key lesion was also higher in stage IV ranged 6-35. The limitations of the study are-the study population was selected from one tertiary hospital in Dhaka city, so that the results of the study may not reflect the exact prevalence of lymphoma of the country. The present study was conducted at a very short period of time. Small sample size was also a limitation of the present study. Therefore, in future further study may be under taken with large sample size.
CONCLUSION
In this study, 14(53%) patients were upstaged on PET-CT scan based staging in comparison to clinical staging.
Treatment strategy was planned by baseline staging.
PET-CT plays an important role for accurate staging in lymphoma patients at baseline which increases the accuracy of subsequent response assessment. It is recently worldwide established that PET-CT based staging is superior to conventional staging but in Bangladesh staging is mainly based on clinical assessment as this modern facility is only available in 21
